Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2006 (Vol. 26, No. 18)

WatCut

URL:watcut.uwaterloo.ca/watcut/watcut/template.php
  • Simple
  • Could use more functions
My involvement with scientific computing began in 1985, with a program I wrote to identify restriction sites on an old Apple IIe computer. We sold a few packages because we had the fastest such program on the market at the time. I think of that as I look at WatCut. Simple sequence manipulations, such as restriction site identification, have been trivial for some time, but this information is still needed. Like many other analyses, sites identification is available for free online. WatCut is one such offering. Operating the program is simple—load a DNA sequence from a file or paste it in a text box and the program does its thing. Users can select enzymes, perform silent mutation analysis, do SNP/RFLP analysis, and format output. Best of all, the interface is simple and the price is right.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »